Exosens (EXENS) AI Stock Analysis

• Market Cap: €3.27B
• Dividend Yield: 0.21%
• Average Volume (3M): 187.72K
• Price to Earnings (P/E): 41.7
• Beta (1Y): 0.67
• Revenue Growth: 22.05%
• EPS Growth: 2658.04%
• Country: FR
• Employees: 1,214
• Sector: Technology
• Sector Strength: 88
• Industry: Hardware, Equipment & Parts
• EPS (TTM): 0.74
• Shares Outstanding: 50,936,750
• 10 Day Avg. Volume: 184,892
• 30 Day Avg. Volume: 187,724
• PEG Ratio: 1.44
• Price to Book (P/B): 5.54
• Price to Sales (P/S): 5.27
• P/FCF Ratio: 50.88
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €64.16
• Price Target Upside: -0.14% Downside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 5
• EPS Forecast (FY): 1.89
• Revenue Forecast (FY): €535.54M

• Rating: 62 Neutral
• Price Target: €67.00 ▲(4.28% Upside)
• Action: Reiterated Date: 03/24/26
• Date: Action: Reiterated 03/24/26

The score is driven primarily by improving financial performance (growth, profitability, and deleveraging), tempered by notable 2025 margin compression and weaker cash conversion. Technicals are broadly supportive longer-term but neutral near-term, while the high P/E meaningfully weighs on the overall rating.

Positive Factors

Sustained operating profitability

EBITDA margins near 29–30% across 2024–2025 indicate durable operating leverage and pricing power in specialized optoelectronics. Sustained EBITDA margins support reinvestment, cover fixed R&D and manufacturing costs, and provide a buffer versus cyclical revenue swings over the next 2–6 months.

Negative Factors

Sharp gross-margin compression

A dramatic drop in gross margin suggests structural mix shifts, price pressure, or higher input costs that erode core profitability. Such swings threaten sustained net-margin and cash generation, forcing either margin recovery or structural cost actions to preserve long-term returns.

Exosens Business Overview & Revenue Model

Company Description

Exosens engages in the development, manufacture, and sale of electro-optical technologies in the fields of amplification, and detection and imaging in France, rest of Europe, North America, Asia, Oceania, Africa, and internationally. It offers ima...

Read more

Exosens engages in the development, manufacture, and sale of electro-optical technologies in the fields of amplification, and detection and imaging in France, rest of Europe, North America, Asia, Oceania, Africa, and internationally. It offers ima...

How the Company Makes Money

null...

Exosens Financial Statement Overview

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	468.20M	394.10M	318.80M	200.75M	166.17M
Gross Profit	102.20M	225.60M	176.81M	113.95M	100.03M
EBITDA	142.10M	115.20M	83.91M	51.25M	-101.18M
Net Income	42.70M	30.70M	17.14M	11.21M	-148.97M
Balance Sheet
Total Assets	878.90M	817.00M	656.41M	529.25M	460.52M
Cash, Cash Equivalents and Short-Term Investments	101.90M	150.20M	15.53M	29.00M	15.93M
Total Debt	280.00M	261.28M	311.77M	255.28M	208.11M
Total Liabilities	433.30M	404.40M	452.35M	346.20M	288.41M
Stockholders Equity	445.70M	412.60M	204.06M	183.05M	172.11M
Cash Flow
Free Cash Flow	48.50M	96.20M	19.53M	25.69M	23.07M
Operating Cash Flow	98.60M	96.20M	50.46M	47.48M	42.66M
Investing Cash Flow	-121.20M	-72.70M	-99.64M	-55.48M	-21.26M
Financing Cash Flow	-16.40M	76.30M	35.49M	20.26M	-36.83M

Exosens Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 64.25
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:EXENS, the sentiment is Positive. The current price of 64.25 is below the 20-day moving average (MA) of 65.29, above the 50-day MA of 61.12, and above the 200-day MA of 48.66, indicating a neutral trend. The MACD of 0.56 indicates Positive momentum. The RSI at 51.47 is Neutral, neither overbought nor oversold. The STOCH value of 83.75 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:EXENS.

Exosens Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
PLNW	67 Neutral	€1.01B	33.16	―	1.37%	13.17%	22.60%
EXENS	62 Neutral	€3.27B	41.71	―	0.21%	22.05%	2658.04%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
LACR	54 Neutral	€60.87M	-0.68	-4.96%	5.91%	-29.10%	-173.56%
ALICA	41 Neutral	€34.02M	-120.40	―	2.17%	14.84%	15.82%